Healio6d
Mepolizumab lowers repeat surgery risk for CRSwNP regardless of number of past surgeries
Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...
Pharmaceutical Technology on MSN8d
EMA to review GSK’s Nucala for COPD treatment expansion
The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on ...
Healthline8d
Nucala (Mepolizumab) Cost and Financial Assistance
The active ingredient in Nucala is mepolizumab. (An active ingredient is what makes a drug work.) Nucala is given as an injection under your skin. A healthcare professional may give you these ...
pharmaphorum4d
GSK's Nucala gains US use in rare autoimmune disease
GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...
Pharmabiz7d
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
Healio29d
Adherence to asthma biologics varies by therapy given, tends to be low
Researchers assessed patients receiving omalizumab, dupilumab, mepolizumab, benralizumab, reslizumab or tezepelumab for asthma. Adherence was deemed intermittent based on heatmaps. SAN DIEGO ...
GSK application to expand use of Nucala to COPD accepted for review by EMA
GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal ...
EMA accepts GSK's application to expand Nucala use
GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of ‘Nucala’, or ...